Brian Buntz

23 hours ago | rdworldonline.com | Brian Buntz

A single 192-core, AmpereOne-powered box from ALAFIA Supercomputers has replaced the University of Miami’s crowded HPC cluster. The result? An up to 10x speedup in complex molecular dynamics simulations. That acceleration trimmed runtimes for complex 50-nanosecond simulations of PROTAC ternary systems from over 24 hours to under six hours.

1 day ago | rdworldonline.com | Brian Buntz

Over the past two years, 218-year-old publisher Wiley has repositioned itself in the AI landscape, focusing on specialized “vertical” models over general chatbots.

1 day ago | rdworldonline.com | Brian Buntz

Follow the money and you’ll spot the biology that paid off in 2024. PD-1 immunotherapy kept oncology on top, with Keytruda ringing up $29.5 billion in revenue​​. In obesity and diabetes, the top five GLP-1/GIP incretins (Ozempic, Mounjaro, Wegovy, Rybelsus and Trulicity) pulled in **$46.1 billion**, up a remarkable **37.8 %** year over year. And Dupixent, the IL-4/IL-13 antibody born from cytokine-mapping work, climbed 22% to $14.2 billion​​.

2 days ago | rdworldonline.com | Brian Buntz

A 21‑year‑old who was tossed from Columbia University last month just banked a $5.3 million seed round for “Cluely,” an AI sidekick that feeds real‑time code and answers during job interviews — undetected by Zoom or Google Meet. The startup already tops $3 million in annual recurring revenue and charges $60 a seat, forcing companies like Google and Amazon to rethink how they vet engineers.

2 days ago | rdworldonline.com | Brian Buntz

Throughout April, the Harvard–White House standoff has morphed from a quiet threat into a multi‑front brawl. Harvard sued the Trump administration for unlawful political coercion, the NIH quietly froze routine grant payments, Massachusetts’ governor warned of an East‑Coast “brain drain.” House GOP committees opened probes, and Harvard earlier moved to float $750 million in bonds to keep its labs alive.